Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Lawrence J. Green"'
Autor:
Matthew J. Zirwas, Zoe D. Draelos, Janet DuBois, Leon H. Kircik, Angela Y. Moore, Linda Stein Gold, Javier Alonso-Llamazares, Michael Bukhalo, Suzanne Bruce, Kimmie Eads, Lawrence J. Green, Scott T. Guenthner, Laura K. Ferris, Seth B. Forman, Steven E. Kempers, Edward Lain, Charles W. Lynde, David M. Pariser, Darryl P. Toth, Paul S. Yamauchi, Robert C. Higham, David Krupa, Patrick Burnett, David R. Berk
Publikováno v:
JAMA Dermatology.
ImportanceCurrent topical treatment options for seborrheic dermatitis are limited by efficacy and/or safety.ObjectiveTo assess safety and efficacy of roflumilast foam, 0.3%, in adult patients with seborrheic dermatitis affecting the scalp, face, and/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca1dec1f89c02bd2aeda1f7193cbee56
https://doi.org/10.1001/jamadermatol.2023.0846
https://doi.org/10.1001/jamadermatol.2023.0846
Autor:
Andreas Pinter, Linda Stein Gold, Adam Reich, Lawrence J. Green, Morten Praestegaard, Johan Selmer, April W. Armstrong, Anne Danø, Sunil Dhawan, Jordi Galván, Sandra E. Stallknecht, Paw Trebbien, Matthias Augustin
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADVREFERENCES. 37
Four posters about the novel, fixed-dose calcipotriol and betamethasone dipropionate cream (CAL/BDP cream) based on Poly-Aphron Dispersion (PAD) Technology were presented at the 30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::725c955214fa9df64ad7fcdf8f7e7fe0
https://pubmed.ncbi.nlm.nih.gov/36546465
https://pubmed.ncbi.nlm.nih.gov/36546465
Publikováno v:
J Clin Aesthet Dermatol
The choice of vehicle is an important consideration in the treatment of acne and rosacea. Agents used to treat these common conditions may be limited by multiple factors, including poor stability during storage, limited residence time in the skin and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::90b0097fc08943fa99400dad3e125465
https://pubmed.ncbi.nlm.nih.gov/35642224
https://pubmed.ncbi.nlm.nih.gov/35642224
Autor:
Linda, Stein Gold, Lawrence J, Green, Sunil, Dhawan, Birgitte, Vestbjerg, Morten, Praestegaard, Johan, Selmer
Publikováno v:
Journal of Drugs in Dermatology. 20:420-425
The fixed dose combination of calcipotriene and betamethasone dipropionate (CAL/BDP) is a well-established, efficacious, and safe topical treatment of psoriasis.A Phase 3, multicenter, randomized, investigator-blind, active, and vehicle-controlled tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6fccbcbde68cf25331b70c821476a18
https://doi.org/10.36849/jdd.5653
https://doi.org/10.36849/jdd.5653
Autor:
Mark G, Lebwohl, Leon H, Kircik, Angela Y, Moore, Linda, Stein Gold, Zoe D, Draelos, Melinda J, Gooderham, Kim A, Papp, Jerry, Bagel, Neal, Bhatia, James Q, Del Rosso, Laura K, Ferris, Lawrence J, Green, Adelaide A, Hebert, Terry, Jones, Steven E, Kempers, David M, Pariser, Paul S, Yamauchi, Matthew, Zirwas, Lorne, Albrecht, Alim R, Devani, Mark, Lomaga, Amy, Feng, Scott, Snyder, Patrick, Burnett, Robert C, Higham, David R, Berk
Publikováno v:
JAMA. 328:1073
ImportanceOnce-daily roflumilast cream, 0.3%, a potent phosphodiesterase 4 inhibitor, demonstrated efficacy and was well tolerated in a phase 2b trial of patients with psoriasis.ObjectiveTo evaluate the efficacy of roflumilast cream, 0.3%, applied on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565d537d0b59fe6b651c8d0f333ec1af
https://doi.org/10.1001/jama.2022.15632
https://doi.org/10.1001/jama.2022.15632
Autor:
Kim A. Papp, David N. Adam, Melinda J. Gooderham, Lawrence J. Green, Mark Lebwohl, Angela Y. Moore, David M. Pariser, Amy Feng, Robert C. Higham, Patrick Burnett, David R. Berk
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB180
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ae5299b1ea1aaa0908c94d09bc0c0d0
https://doi.org/10.1016/j.jaad.2022.06.753
https://doi.org/10.1016/j.jaad.2022.06.753
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB105
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1266679cbf3059ab18a5d9681ef14ca0
https://doi.org/10.1016/j.jaad.2022.06.455
https://doi.org/10.1016/j.jaad.2022.06.455
Autor:
Linda Stein Gold, Jerry Bagel, James Del Rosso, Lawrence J. Green, Mark Lebwohl, Leon H. Kircik, Amy Feng, Scott Snyder, Robert C. Higham, Patrick Burnett, David R. Berk
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB192
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8764100f3a0737cf2a328b65c82a709c
https://doi.org/10.1016/j.jaad.2022.06.799
https://doi.org/10.1016/j.jaad.2022.06.799
Publikováno v:
Journal of drugs in dermatology : JDD. 20(6)
Two identical phase 3 trials (NCT03168321 and NCT03168334) and pooled post hoc analyses have established efficacy and safety of a polymeric tazarotene 0.045% lotion formulation in patients with moderate-to-severe acne. Presented here are post hoc ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::24d2c218e68a00bab0e836034d450484
https://pubmed.ncbi.nlm.nih.gov/34076400
https://pubmed.ncbi.nlm.nih.gov/34076400
Publikováno v:
Journal of drugs in dermatology : JDD. 18(8)
Psoriasis (PsO) is a common, systemic, chronic inflammatory disease characterized by key clinical symptoms, including itching, pain, and scaling, and is associated with substantial physical, psychosocial, and economic health burdens. Currently, there
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::265cb69736c98c968f35c9cab3d1a67f
https://pubmed.ncbi.nlm.nih.gov/31424708
https://pubmed.ncbi.nlm.nih.gov/31424708